High expression of SLC1A5 was associated with aggressive clinicopathological parameters including larger tumor size, poor Nottingham Prognostic Index (NPI), high tumor grade, vascular invasion, and high Ki67 expression (A cut-off point of 10 was used to define its positivity) (P < 0.05), Table 1. This evidence concerns the gene SLC1A5 and neoplasm.